Bartlett & Co Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $182K | Buy |
347
+3
| +0.9% | +$1.58K | ﹤0.01% | 458 |
|
2025
Q1 | $218K | Hold |
344
| – | – | ﹤0.01% | 435 |
|
2024
Q4 | $245K | Hold |
344
| – | – | ﹤0.01% | 413 |
|
2024
Q3 | $362K | Hold |
344
| – | – | 0.01% | 372 |
|
2024
Q2 | $362K | Sell |
344
-2
| -0.6% | -$2.1K | 0.01% | 364 |
|
2024
Q1 | $333K | Buy |
346
+2
| +0.6% | +$1.93K | 0.01% | 387 |
|
2023
Q4 | $303K | Hold |
344
| – | – | ﹤0.01% | 413 |
|
2023
Q3 | $283K | Hold |
344
| – | – | 0.01% | 406 |
|
2023
Q2 | $247K | Hold |
344
| – | – | ﹤0.01% | 426 |
|
2023
Q1 | $283K | Hold |
344
| – | – | 0.01% | 347 |
|
2022
Q4 | $248K | Hold |
344
| – | – | 0.01% | 354 |
|
2022
Q3 | $237K | Hold |
344
| – | – | 0.01% | 351 |
|
2022
Q2 | $203K | Hold |
344
| – | – | ﹤0.01% | 370 |
|
2022
Q1 | $240K | Hold |
344
| – | – | ﹤0.01% | 365 |
|
2021
Q4 | $217K | Hold |
344
| – | – | ﹤0.01% | 381 |
|
2021
Q3 | $208K | Sell |
344
-9
| -3% | -$5.45K | ﹤0.01% | 331 |
|
2021
Q2 | $197K | Hold |
353
| – | – | ﹤0.01% | 333 |
|
2021
Q1 | $167K | Hold |
353
| – | – | ﹤0.01% | 344 |
|
2020
Q4 | $171K | Buy |
353
+9
| +3% | +$4.35K | ﹤0.01% | 341 |
|
2020
Q3 | $193K | Hold |
344
| – | – | ﹤0.01% | 313 |
|
2020
Q2 | $215K | Buy |
344
+135
| +65% | +$84.2K | 0.01% | 303 |
|
2020
Q1 | $102K | Hold |
209
| – | – | ﹤0.01% | 367 |
|
2019
Q4 | $78.5K | Hold |
209
| – | – | ﹤0.01% | 441 |
|
2019
Q3 | $58K | Buy |
209
+168
| +410% | +$46.6K | ﹤0.01% | 503 |
|
2019
Q2 | $12.8K | Buy |
41
+1
| +3% | +$313 | ﹤0.01% | 571 |
|
2019
Q1 | $16.4K | Hold |
40
| – | – | ﹤0.01% | 536 |
|
2018
Q4 | $14.9K | Hold |
40
| – | – | ﹤0.01% | 543 |
|
2018
Q3 | $16.2K | Hold |
40
| – | – | ﹤0.01% | 561 |
|
2018
Q2 | $13.8K | Hold |
40
| – | – | ﹤0.01% | 569 |
|
2018
Q1 | $13.8K | Buy |
+40
| New | +$13.8K | ﹤0.01% | 577 |
|